Expert webinars, monthly live updates, and on-demand congress highlights — all peer-reviewed, clinician-led, and free from commercial bias.
Expert-led, peer-reviewed sessions covering the latest developments in diabetes technology. Free to attend with optional CME credit.
CGM offers more possibilities than are often used in clinical practice. Participants will learn when standard settings fall short and how small adjustments in alarms, glucose targets, and data interpretation can make a major difference for individual patients.
How artificial intelligence supports earlier detection of diabetes complications — including diabetic retinopathy, neuropathy, kidney disease, and cardiovascular disease. Practical examples, current limitations, and a glimpse into the future of AI in diabetology.
Join us for a curated roundup of the most relevant diabetes technology developments — devices, studies, regulatory changes, and real-world clinical implications from the latest ATTD conference.
Each month, we curate and translate the most relevant developments in diabetes technology — so clinicians and teams stay current without information overload.
Focused on clinical relevance — devices, studies, regulatory changes, and real-world implications.
Fully independent. No commercial influence — just honest, peer-reviewed information.
For individual clinicians, clinical teams, and healthcare organizations who need to stay consistently up to date.
Can't attend live? Full recordings and slide decks are available to platform members after each session.
Included with full Diabetotech platform membership. Non-members may join individual sessions via Zoom registration.
Catch up on previous sessions and congress highlights. Recordings available to all — slides for live attendees only.
Subscribe to our newsletter and get notified about upcoming events, congress highlights, and the latest developments in diabetes technology. Join 11,000+ subscribers — available in English & Dutch.